Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengba Pharma, officially Guizhou Hengba Pharmaceutical Limited Liability Company, is a Chinese pharmaceutical company specializing in the development and production of Traditional Chinese Medicine (TCM) and ethnic Miao medicines. Founded in 1995 and based in Guiyang, the company is best known for its proprietary treatments for burns, scalds, and bone injuries, notably its flagship product Shangkeling spray. Hengba operates multiple GMP-certified production lines for sprays, tablets, capsules, and granules, serving a broad domestic market in China. In 2024, the company was acquired by Huadong Medicine for approximately 528 million yuan to strengthen Huadong's portfolio in the external medicine and TCM sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengba Pharma.